Mannkind reported $-9610000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Adma Biologics ADMA:US USD 22.12M 31.29M
Biocryst Pharmaceuticals BCRX:US USD -17445000 17.28M
Dynavax Technologies DVAX:US USD 61.4M 66.83M
Eli Lilly And LLY:US USD 1.68B 466.4M
Halozyme Therapeutics HALO:US USD 80.58M 46.52M
Immunogen IMGN:US USD -77429000 16.38M
Insmed INSM:US USD -127697000 39.38M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Mannkind MNKD:US USD -9610000 10.84M
Merk MRK:US USD 3.99B 939M
Minerva Neurosciences NERV:US USD -5207000 1.76M
Novavax NVAX:US USD -127189000 355.77M
Novo Nordisk A Fs NVO:US DKK 20.18B 1.79B
Peregrine Pharmaceuticals PPHM:US USD 2.74M 1.67M
Pfizer PFE:US USD 9.41B 2.69B
Xencor XNCR:US USD -38348000 10.35M